Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688050's EV-to-FCF is ranked worse than 71.74% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.2
vs SHSE:688050: 41.01
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eyebright Medical Technology (Beijing) Co (SHSE:688050) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eyebright Medical Technology (Beijing) Co's PE Ratio (TTM) for today is calculated as:
Eyebright Medical Technology (Beijing) Co's share price for today is ¥41.49.
Eyebright Medical Technology (Beijing) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.370.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Eyebright Medical Technology (Beijing) Co EV-to-FCF Related Terms
Eyebright Medical Technology (Beijing) Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co EV-to-FCF Chart
Eyebright Medical Technology (Beijing) Co Annual Data
SHSE:688050 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eyebright Medical Technology (Beijing) Co EV-to-FCF vs Medical Devices & Instruments Industry
Eyebright Medical Technology (Beijing) Co's current Enterprise Value is ¥8,793 Mil.
Eyebright Medical Technology (Beijing) Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥214 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co (SHSE:688050) has a EV-to-FCF of 41.01 as of Jul. 20, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. According to the industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #297 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 71.7%.
Is Eyebright Medical Technology (Beijing) Co's EV-to-FCF too high?
Eyebright Medical Technology (Beijing) Co's current EV-to-FCF is 41.01. The Medical Devices & Instruments industry median EV-to-FCF is 23.20. Eyebright Medical Technology (Beijing) Co's value of 41.01 is 76.8% above this industry median. Based on the distribution chart, Eyebright Medical Technology (Beijing) Co ranks #297 out of 414 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eyebright Medical Technology (Beijing) Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Eyebright Medical Technology (Beijing) Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #297 out of 414 companies for EV-to-FCF. This places Eyebright Medical Technology (Beijing) Co in the lower half of its industry. The industry median EV-to-FCF is 23.20. Eyebright Medical Technology (Beijing) Co's value of 41.01 is 76.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.20, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eyebright Medical Technology (Beijing) Co's current EV-to-FCF of 41.01 is 76.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eyebright Medical Technology (Beijing) Co's current EV-to-FCF is 41.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eyebright Medical Technology (Beijing) Co stock overvalued right now?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co (SHSE:688050) is currently considered Possible Value Trap. The stock's GF Value™ is ¥112.14, compared to a current price of ¥41.49 — trading 63% below its estimated fair value. The current EV-to-FCF is 41.01 and 76.8% above the Medical Devices & Instruments industry median of 23.20. Eyebright Medical Technology (Beijing) Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Eyebright Medical Technology (Beijing) Co (SHSE:688050), the current EV-to-FCF is 41.01 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eyebright Medical Technology (Beijing) Co (SHSE:688050) Overvalued in 2026?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co stock appears to be undervalued.
The current stock price of ¥41.49 is trading 63% below its estimated GF Value™ of ¥112.14.
GuruFocus considers Eyebright Medical Technology (Beijing) Co to be Possible Value Trap.
Key valuation signals for SHSE:688050:
EV-to-FCF: 41.01
GF Value™: ¥112.14 vs. price of ¥41.49 (63% below fair value)
Industry Position: 76.8% above the Medical Devices & Instruments median (#297 of 414)
No single metric tells the full story. See the SHSE:688050 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eyebright Medical Technology (Beijing) Co Business Description
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
74GF Score
Get the complete analysis for SHSE:688050
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688050 has been successfully added to your 
